BII
ADMS

Bainco International Investors’s Adamas Pharmaceuticals ADMS Stock Holding History

Bainco International Investors’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-24,000
Closed -$171K – 88
2019
Q1 		$171K Buy
24,000
+10,000
+71% +$89.9K 0.03% 81
2018
Q4 		$120K Sell
14,000
-20,100
-59% -$261K 0.02% 92
2018
Q3 		$683K Hold
34,100
– – 0.09% 70
2018
Q2 		$881K Sell
34,100
-40,000
-54% -$1.11M 0.13% 69
2018
Q1 		$1.77M Buy
74,100
+54,000
+269% +$1.7M 0.26% 62
2017
Q4 		$681K Buy
+20,100
New +$561K 0.1% 71

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Bainco International Investors's ADMS Position: Q2 2019 in Review

Bainco International Investors sold out of Adamas Pharmaceuticals (ADMS) in Q2 2019, closing a stake of 24,000 shares — an estimated $171K sold.

Bainco International Investors first reported a position in ADMS in Q4 2017 and held it in 6 quarters. The position peaked at $1.77M in Q1 2018. 78 funds tracked by Wall St. Rank hold ADMS as of Q2 2019.

  • Bainco International Investors reported no remaining Adamas Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Bainco International Investors sold 24,000 Adamas Pharmaceuticals shares in Q2 2019, an estimated $171K.
  • Bainco International Investors first reported a position in Adamas Pharmaceuticals in Q4 2017 and held it in 6 quarters.
  • Bainco International Investors's Adamas Pharmaceuticals position peaked at $1.77M in Q1 2018.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2019.

Based on Bainco International Investors's 13F filing for Q2 2019, filed 22 Jul 2019.